Your browser doesn't support javascript.
loading
Increased platelet sensitivity toward platelet inhibitors during physical exercise in patients with coronary artery disease.
Lindemann, S; Klingel, B; Fisch, A; Meyer, J; Darius, H.
Afiliação
  • Lindemann S; Department of Medicine II, Johannes Gutenberg-University, Mainz, Germany.
Thromb Res ; 93(2): 51-9, 1999 Jan 15.
Article em En | MEDLINE | ID: mdl-9950258
Generalized atherosclerosis and coronary artery disease (CAD) are associated with endothelial dysfunction and during acute myocardial ischemia platelet activation has been reported. Activated platelets exert activated fibrinogen receptors (GP IIb/IIIa) and express CD 62p being regarded as reliable marker for platelet activation. Patients with angiographically proven CAD performed a bicycle exercise test until the onset of angina or ST-segment depression. We studied the ischemia-induced alterations in fibrinogen binding to activated platelet GP IIb/IIIa receptors and CD 62p expression. Therefore, the basal fibrinogen binding to GP IIb/IIIa and CD 62p expression and the thrombin-concentration for half-maximal platelet activation before and after exercise testing were determined. Additionally, inhibition of thrombin-induced platelet activation by increasing concentrations of the prostacyclin-analog iloprost and the NO-donor SIN-1 was examined. In patients with CAD, a significantly reduced basal activation and a highly significant reduction in sensitivity towards thrombin was measured. The thrombin-induced expression of GP IIb/IIIa and CD 62p was significantly diminished in patients with CAD after physical exercise and their platelets were significantly more sensitive towards the inhibitory effects of iloprost and SIN-1. These data demonstrate a significant reduction in platelet activation in response to physical exercise in patients with CAD and advanced atherosclerosis. Despite exercise induced myocardial ischemia as evidenced by angina and ECG-changes, the platelets are not generally activated, as it could be expected. Thus, patients with myocardial ischemia experienced a reduced platelet activity and enhanced sensitivity towards prostacyclin (PGI2) and nitric oxide, probably due to an augmented release of endogenous platelet inhibitory mediators.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plaquetas / Inibidores da Agregação Plaquetária / Doença das Coronárias Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Revista: Thromb Res Ano de publicação: 1999 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Estados Unidos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plaquetas / Inibidores da Agregação Plaquetária / Doença das Coronárias Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Revista: Thromb Res Ano de publicação: 1999 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Estados Unidos